Therapeutic apheresis for myositises

Transfusion and Apheresis Science

Volumn 36, Issue 2, 2007, Pages 169-172

  Le Guern, Véronique ^a   Guillevin, Loïc ^a  

^a AP HP ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; HUMAN; MYOSITIS; PLASMAPHERESIS;

ANTIBODY FORMATION; BLOOD COMPONENT REMOVAL; HUMANS; MYOSITIS; PLASMA EXCHANGE;

EID: 34248184010     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.01.008     Document Type: Article

References (27)

1. Dalakas M.C., and Hohlfeld R. Polymyositis and dermatomyositis. Lancet 362 9388 (2003) 971-982
2. Hoogendijk J.E., Amato A.A., Lecky B.R., Choy E.H., Lundberg I.E., Rose M.R., et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscular Disord 14 5 (2004) 337-345
3. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292 7 (1975) 344-347
4. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292 8 (1975) 403-407
5. Selva-O'Callaghan A., Labrador-Horrillo M., Solans-Laque R., Simeon-Aznar C.P., Martinez-Gomez X., and Vilardell-Tarres M. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55 5 (2006) 791-798
6. Troyanov Y., Targoff I.N., Tremblay J.L., Goulet J.R., Raymond Y., and Senecal J.L. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84 4 (2005) 231-249
7. Hengstman G.J., ter Laak H.J., Vree Egberts W.T., Lundberg I.E., Moutsopoulos H.M., Vencovsky J., et al. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65 12 (2006) 1635-1638
8. Choy E.H., and Isenberg D.A. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford) 41 1 (2002) 7-13
9. Patten E. Therapeutic plasmapheresis and plasma exchange. Crit Rev Clin Lab Sci 23 2 (1986) 147-175
10. Khatri B.O., Luprecht G., and Weiss S.A. Plasmapheresis and immunosuppressive drug therapy in polymyositis. Muscle Nerve 5 7 (1982) 568-569
11. Brewer Jr. E.J., Giannini E.H., Rossen R.D., Patten B., and Barkley E. Plasma exchange therapy of a childhood onset dermatomyositis patient. Arthritis Rheum 23 4 (1980) 509-513
12. Dau P.C. Plasmapheresis in idiopathic inflammatory myopathy. Experience with 35 patients. Arch Neurol 38 9 (1981) 544-552
13. Bennington J.L., and Dau P.C. Patients with polymyositis and dermatomyositis who undergo plasmapheresis therapy. Pathologic findings. Arch Neurol 38 9 (1981) 553-560
14. Clarke C.R., Dyall-Smith D.J., Mackay I.R., Emery P., Jennens I.D., and Becker G. Plasma exchange in dermatomyositis/polymyositis: beneficial effects in three cases. J Clin Lab Immunol 27 3 (1988) 149-152
15. Herson S., Lok C., Roujeau J.C., Coutellier A., Etienne S.D., Revuz J., et al. Plasma exchange in dermatomyositis and polymyositis. Retrospective study of 38 cases of plasma exchange. Ann Med Interne (Paris) 140 6 (1989) 453-455
16. Lok C., Herson S., Roujeau J.C., Revuz J., Gerard A., and Godeau P. Plasma exchange in dermatomyositis. A retrospective study of 21 cases. Ann Dermatol Venereol 116 3 (1989) 219-224
17. Cherin P., Auperin I., Bussel A., Pourrat J., and Herson S. Plasma exchange in polymyositis and dermatomyositis: a multicenter study of 57 cases. Clin Exp Rheumatol 13 2 (1995) 270-271
18. Cherin P., and Herson S. Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins. Ann Med Interne (Paris) 144 8 (1993) 521-525
19. Miller F.W., Leitman S.F., Cronin M.E., Hicks J.E., Leff R.L., Wesley R., et al. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 326 21 (1992) 1380-1384
20. Smith J.W., Weinstein R., and For the AHCKL. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 43 6 (2003) 820-822
21. Euler H., and Shroeder J. Antibody depletion and cytotoxic drug therapy in severe systemic lupus erythematosus. Transfus. Sci. 13 (1992) 167-184
22. Bussel A., Boulechfar H., and Naim R. Immunoglobulins or plasma exchange? Synchronization of plasma exchange and intravenous polyvalent immunoglobulins. A consecutive study of 11 patients. Ann Med Interne (Paris) 144 8 (1993) 532-538
23. Nydegger U.E., and Sturzenegger T. Treatment of autoimmune disease: synergy between plasma exchange and intravenous immunoglobulins. Ther Apher 5 3 (2001) 186-192
24. Arlet J.B., Dimitri D., Pagnoux C., Boyer O., Maisonobe T., Authier F.J., et al. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP). Neuromuscul Disord 16 5 (2006) 334-336
25. Noss E.H., Hausner-Sypek D.L., and Weinblatt M.E. Rituximab as therapy for refractory polymyositis and dermatomyositis. J Rheumatol 33 5 (2006) 1021-1026
26. Lambotte O., Kotb R., Maigne G., Blanc F.X., Goujard C., and Delfraissy J.F. Efficacy of rituximab in refractory polymyositis. J Rheumatol 32 7 (2005) 1369-1370
27. Chiappetta N., Steier J., and Gruber B. Rituximab in the treatment of refractory dermatomyositis. J Clin Rheumatol 11 5 (2005) 264-266